Narrative review / 2008
Pharmacological doses of nicotinic acid alter lipid profiles, increase HDL cholesterol, and may lower cardiovascular risk, but can cause flushing.
This review examines the pharmacological effects and mechanisms of nicotinic acid. Pharmacological doses alter plasma lipids and lipoproteins and strongly increase HDL cholesterol. Evidence indicates that nicotinic acid, alone or alongside LDL-lowering drugs, can reduce atherosclerosis progression and cardiovascular event risk. However, its clinical application is hindered by unpleasant side effects such as cutaneous vasodilation (flushing).
- Study type
- Narrative review
- Who was studied
- Patients with dyslipidemia or cardiovascular disease risks (not quantified)
- What was measured
- Lipid/lipoprotein changes, atherosclerosis progression, cardiovascular events, flushing
THE PAPER
Nicotinic acid: pharmacological effects and mechanisms of action.
Gille A, Bodor ET, Ahmed K, Offermanns S. Annu Rev Pharmacol Toxicol, 2008.
PubMed 17705685 ↗DOI 10.1146/annurev.pharmtox.48.113006.094746 ↗
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.